Cargando…

Metabolic alterations due to IDH1 mutation in glioma: opening for therapeutic opportunities?

Detalles Bibliográficos
Autores principales: N Mustafa, Dana A, Swagemakers, Sigrid M, Buise, Laura, van der Spek, Peter J, Kros, Johan M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3896697/
https://www.ncbi.nlm.nih.gov/pubmed/24405933
http://dx.doi.org/10.1186/2051-5960-2-6
_version_ 1782300113779032064
author N Mustafa, Dana A
Swagemakers, Sigrid M
Buise, Laura
van der Spek, Peter J
Kros, Johan M
author_facet N Mustafa, Dana A
Swagemakers, Sigrid M
Buise, Laura
van der Spek, Peter J
Kros, Johan M
author_sort N Mustafa, Dana A
collection PubMed
description
format Online
Article
Text
id pubmed-3896697
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-38966972014-01-22 Metabolic alterations due to IDH1 mutation in glioma: opening for therapeutic opportunities? N Mustafa, Dana A Swagemakers, Sigrid M Buise, Laura van der Spek, Peter J Kros, Johan M Acta Neuropathol Commun Letter to the Editor BioMed Central 2014-01-09 /pmc/articles/PMC3896697/ /pubmed/24405933 http://dx.doi.org/10.1186/2051-5960-2-6 Text en Copyright © 2014 Mustafa et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Letter to the Editor
N Mustafa, Dana A
Swagemakers, Sigrid M
Buise, Laura
van der Spek, Peter J
Kros, Johan M
Metabolic alterations due to IDH1 mutation in glioma: opening for therapeutic opportunities?
title Metabolic alterations due to IDH1 mutation in glioma: opening for therapeutic opportunities?
title_full Metabolic alterations due to IDH1 mutation in glioma: opening for therapeutic opportunities?
title_fullStr Metabolic alterations due to IDH1 mutation in glioma: opening for therapeutic opportunities?
title_full_unstemmed Metabolic alterations due to IDH1 mutation in glioma: opening for therapeutic opportunities?
title_short Metabolic alterations due to IDH1 mutation in glioma: opening for therapeutic opportunities?
title_sort metabolic alterations due to idh1 mutation in glioma: opening for therapeutic opportunities?
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3896697/
https://www.ncbi.nlm.nih.gov/pubmed/24405933
http://dx.doi.org/10.1186/2051-5960-2-6
work_keys_str_mv AT nmustafadanaa metabolicalterationsduetoidh1mutationingliomaopeningfortherapeuticopportunities
AT swagemakerssigridm metabolicalterationsduetoidh1mutationingliomaopeningfortherapeuticopportunities
AT buiselaura metabolicalterationsduetoidh1mutationingliomaopeningfortherapeuticopportunities
AT vanderspekpeterj metabolicalterationsduetoidh1mutationingliomaopeningfortherapeuticopportunities
AT krosjohanm metabolicalterationsduetoidh1mutationingliomaopeningfortherapeuticopportunities